// App-Quantinova.ai

OP0285 : TOWARDS IMPLEMENTING THE OMOP CDM ACROSS FIVE EUROPEAN BIOLOGIC REGISTRIES

Researchers

Presenter

  • E. Burn

Principal Investigators

  • L. Kearsley-Fleet

  • K. Hyrich

  • M. Schaefer

  • D. Huschek

  • A. Strangfeld

  • J. Zavada

  • M. Lagov

  • D. Courvoisier

  • C. Tellenbach

  • K. Lauper

  • C. Snchez-Piedra

  • N. Montero

  • J. T. Sanchez-Costa

  • D. Prieto-Alhambra

Medical Centers

  • University of Oxford, Oxford, United Kingdom

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • University of Manchester, Manchester Academic Health Centre, Centre for Epidemiology Versus Arthritis, Manchester, United Kingdom

  • Epidemiology unit, German Rheumatism Research Center, Berlin, Germany

  • Institute of Rheumatology, Prague, Czech Republic

  • Institute of Biostatistics and Analyses, Brno, Czech Republic

  • Division of Rheumatology, University Hospital Geneva, Switzerland

  • Swiss Clinical Quality Management in Rheumatic Diseases-SCQM Foundation, Zurich, Switzerland

  • Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom

  • Research Unit of Spanish Society of Rheumatology,, Madrid, Spain

Locations

  • United Kingdom

  • Germany

  • Czech Republic

  • Switzerland

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved